Document is current
Any future updates will be listed below
-
Authors
Tao, Weijing
Zhang, Jinglin
Meng, Xin
Han, Xuedong
Wang, Qiuhu
Lin, Yixiang
Cheng, Luyi
Liu, Minmin
Da, Dongzhu
Zhang, Huai
Fan, Junfu
Zhang, Lianmei
Liu, Shuangyue
Li, Shuo
Gao, Feng
Ren, Yi
-
Funding
Funding for this research was provided by:
the project of Nanjing Medical University - Qilu Clinical Research Foundation and the project of Tumours Individualized Medical Cooperative Innovation Center by Nanjing Medical University (KY218CXY2024019)
Chinese Society of Clinical Oncology (2024CICCPMHR018)
- License Information
-
More Information
Article History
Received: 8 February 2025
Accepted: 10 April 2025
First Online: 21 April 2025
Declarations
:
: Animal experiments were conducted following the regulations approved by the Animal Ethics Committee of Shandong University (ECSBMSSDU2021-2-24). Human studies were approved by the Ethics Committee of Huai’an First People’s Hospital (Approval No. KY-2023-09-01).
: Informed consent was obtained from all individual participants included in the study.
: All authors declare they have no relevant financial or non-financial interests that are directly or indirectly related to the work submitted for publication.
: The clinical evaluation of this study was registered On October 25, 2024 at (No: ChiCTR2400091303).
